Skip to main content

Table 1 Demographics of patients and controls at baseline

From: Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors

Characteristics

Testicular Cancer Patients

n = 64

Childhood Cancer Survivors

n = 90

Patients Total

n = 154

Controls

n = 44

Age, mean (SD)

34.6 (7.1)

30.5 (5.6)

32.2 (6.5)

36.0 (6.7)

LHa,b, median (range)

5.6 (2.0–23.0)

4.2 (1.1–15.0)

4.5 (1.1–23.0)

3.0 (1.0–8.2)

TTa, mean (SD)

13.1 (2.9)

15.8 (5.5)

14.7 (4.8)

15.6 (4.1)

Gonadal statusc, n (%)

 Eugonadal wo TRT

46 (72)

67 (74)

113 (73)

43 (98)

 Secondary HG wo TRT

4 (6)

9 (10)

13 (8)

1 (2)

 Primary wo TRT

0 (0)

0 (0)

0 (0)

0 (0)

 Compensated wo TRT

3 (5)

4 (4)

7 (5)

0 (0)

 Eugonadal w TRT

1 (2)

8 (9)

9 (6)

0 (0)

 Secondary HG w TRT

1 (2)

1 (1)

2 (1)

0 (0)

 Primary w TRT

1 (2)

1 (1)

2 (1)

0 (0)

 Compensated w TRT

1 (2)

0 (0)

1 (1)

0 (0)

 Unknown w TRT

1 (2)

0 (0)

1 (1)

0 (0)

Hypogonadalc, n (%)

 No

46 (72)

67 (74)

113 (73)

43 (98)

 Yes

12 (19)

23 (26)

35 (23)

1 (2)

  1. aData missing on 7 TCP. bData missing on 7 CCS. cData missing on 6 TCP. LH Luteinizing hormone, TT Total testosterone, TRT Testosterone replacement therapy, wo Without, w With